Abstract
ObjectiveTumour necrosis factor inhibitors (TNFi) are effective in rheumatoid arthritis (RA), but disadvantages include adverse events (AEs) and high costs. This can be improved by disease activity-guided dose reduction (DR)....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have